CONFERENCE PROCEEDING
The TackSHS Project. Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations
Esteve Fernández 1, 2, 3
,  
Olena Tigova 1, 2  
,  
Mª José López 4, 5, 6
,  
Sean Semple 8
,  
Luke Clancy 9
,  
Panagiotis K. Behrakis 10, 11, 12
,  
Roberto Boffi 13
,  
Giuseppe Gorini 14
,  
 
 
More details
Hide details
1
WHO Collaborating Center for Tobacco Control, Tobacco Control Unit, Institut Català d’Oncologia-ICO, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
2
Cancer Prevention and Control Group, Institut d’Investigació Biomèdica de Bellvitge, L’Hospitalet de Llobregat, Catalonia, Barcelona, Spain
3
Departament of Clinical Sciences, School of Medicine, Campus de Bellvitge, Universitat de Barcelona, L’Hospitalet del Llobregat, Catalonia, Barcelona, Spain
4
Agència de Salut Pública de Barcelona, Barcelona, Spain
5
CIBER de Epidemiología y Salud Pública, Madrid, Spain
6
Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain
7
Istituto Di Ricerche Farmacologiche Mario Negri, Department of Epidemiology, Milan, Italy
8
University of Aberdeen, Division of Applied Health Sciences, Aberdeen, UK
9
TobaccoFree Research Institute Ireland, Dublin, Ireland
10
George D Behrakis Research Lab, Hellenic Cancer Society, Athens, Greece
11
Biomedical Research Foundation, Academy of Athens, Athens, Greece
12
American College of Greece, Institute of Public Health, Athens, Greece
13
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
14
Cancer Prevention and Research Institute, Unit of Environmental and Occupational Epidemiology, Florence, Italy
15
Universidad Politécnica de Cartagena, Departamento de Economía, Cartagena, Murcia, Spain
16
Centre de Recerca en Economia i Salut, Universitat Pompeu Fabra, Barcelona, Spain
17
European Network for Smoking Prevention, Brussels, Belgium
18
Research Institute of Hospital University La Princesa, University Autónoma of Madrid, Spain
Publish date: 2017-05-25
Submission date: 2017-04-19
Acceptance date: 2017-04-20
 
Tob. Prev. Cessation 2017;3(May Supplement):21
KEYWORDS:
ABSTRACT:
Introduction:
Exposure to secondhand smoke (SHS) is classified as a Group 1 carcinogen by the International Agency for Research on cancer and has been shown to have adverse health effects on adults and children, including heart and respiratory diseases. Electronic cigarettes (e-cigarettes) have irrupted in the market with sales volumes increasing considerably across the EU. The TackSHS Project is aimed to elucidate the impact that SHS and e-cigarette aerosols have on the respiratory health and how health effects vary according to socio-economic parameters with particular emphasis on specific vulnerable groups (patients suffering from chronic lung diseases, heavy smokers, etc.).

Material and Methods:
Through an integrated series of workpackages, the TackSHS Project will investigate the determinants of SHS exposure, both assessed at the individual level and in the environment (survey and SHS assessment in 12 countries), the overall burden of disease caused (lung diseases and cardiovascular diseases), including the specific respiratory health changes in patients and healthy people, the economic impact of both mortality and morbidity caused by these exposures, the methods to characterize these exposures and novel interventions to reduce them.

Results:
This integrated approach will enable significant step-change beyond the state-of-the-art in understanding SHS and e-cigarette aerosols exposure. The Project will put together for the first time the first-line research teams, and the conjunction of the workpackages will result in a step forward to tackle exposure to SHS and e-cigarettes aerosols.

Conclusions:
TackSHS is a four-year project that started in 2015.

Funding:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 681040

CORRESPONDING AUTHOR:
Olena Tigova   
Cancer Prevention and Control Group, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Granvia de L’Hospitalet, 199-203, 08908, Barcelona, Spain
eISSN:2459-3087